AT-9311

N/A

Report date: 2026/01/06 15:22:21

Base Information

Drug NameAT-9311
Drug Alias NameNVP-LCQ195
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 1 inhibitorsCyclin-dependent kinase 2 inhibitorsCyclin-dependent kinase 9 inhibitors +[5] 
TargetsCyclin-dependent kinase 1Cyclin-dependent kinase 2Cyclin-dependent kinase 9 +[5] 
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgAstex Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A